FCGRT and myasthenia gravis: Moreover, according to the latest German guidelines for myasthenia gravis, neonatal Fc receptor (FcRn) antagonists are a an optimal therapeutic choice for patients experiencing acute MG exacerbations requiring rapid antibody depletion (18).